Paper Details

  1. Home
  2. Paper Details

Teletherapy and radiopharmaceutical therapy of painful bone metastases.

Author: SilbersteinEdward B

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This paper discusses the use of radiopharmaceuticals for the treatment of bone pain caused by osteoblastic metastases.
Paper Details　
Original Abstract of the Article :
Bone pain from metastatic disease is most common in cancers of the breast, prostate, and lung. Despite the World Health organization algorithm for treating such pain, the outcomes are not often satisfactory. In 2005, there will be 3 radiopharmaceuticals available in the United States that can reduce...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1053/j.semnuclmed.2004.11.006

データ提供：米国国立医学図書館（NLM）

Radiotherapy for Painful Bone Metastases: A Targeted Approach to Relieving Pain

Bone metastases, the spread of cancer cells to bones, are a common complication of advanced cancer, causing significant pain and discomfort. Radiotherapy, particularly radiopharmaceutical therapy, has proven effective in managing bone pain associated with metastases. This study explores the use of radiopharmaceuticals in treating painful bone metastases, examining their effectiveness, side effects, and potential benefits.

Radiopharmaceuticals: A Potential Solution for Painful Bone Metastases

The study highlights the efficacy of radiopharmaceuticals like phosphorus-32, strontium-89, and samarium-153 in relieving bone pain associated with metastases. While side effects are common, they are generally mild and manageable. The study also suggests that strontium-89 may reduce the incidence of new bone metastases. These findings offer hope for patients experiencing painful bone metastases, providing a targeted approach to managing their pain and improving their quality of life.

Managing Painful Bone Metastases: A Multidisciplinary Approach

The study emphasizes the importance of a multidisciplinary approach to managing painful bone metastases. Radiopharmaceuticals play a crucial role in pain management, but a comprehensive treatment plan should also include pain medications, supportive care, and other therapies. This study encourages patients to work closely with their healthcare team to develop an individualized plan that addresses their specific needs and optimizes their overall well-being.

Dr. Camel's Conclusion

This study offers a glimpse into the evolving landscape of cancer care, with a focus on managing pain and improving quality of life. Just as a camel adapts to the desert environment, physicians must continually seek new ways to manage the challenges of advanced cancer. This study highlights the potential of radiopharmaceuticals in treating painful bone metastases, providing a targeted approach to relieve pain and enhance the lives of individuals facing this challenge.

Date :
  1. Date Completed 2005-06-28
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15765378

DOI: Digital Object Identifier

10.1053/j.semnuclmed.2004.11.006

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.